Needham Downgrades Pacira BioSciences to Hold

Benzinga Newsdesk www.benzinga.com Negative 84.6%

Neg 84.6% Neu 0% Pos 0%

Needham analyst Serge Belanger downgrades Pacira BioSciences (NASDAQ:PCRX) from Buy to Hold.

Comments

No comments yet. Be the first!